SomnoMed® is a global medical device company, founded in 2004 and listed on the Australian Stock Exchange, operating in 28 countries. With headquarters in Sydney, Australia, and offices in Europe and the United States, SomnoMed® specializes in developing and manufacturing clinically proven medical devices for the treatment of Obstructive Sleep Apnea (OSA). Our oral appliances have successfully treated patients worldwide with mild and moderate OSA, providing comfortable and effective solutions.SomnoMed® is a leader in developing OSA devices, with each appliance custom-made using state-of-the-art technology to deliver precision, comfort, and first-time fit solutions. We are committed to continuous improvement, ensuring that our oral sleep medicine devices are highly effective and comfortable. Our devices have received FDA 510(k) clearance and are manufactured in accordance with ISO 13485 quality standards.Our vision is to lead in the treatment of patients suffering from obstructive sleep apnea and relevant adjacent conditions.Our mission is to advance the adoption, acceptance, and treatment of oral sleep apnea therapies by medical specialists, dentists, patients and insurers.While we create potentially life-changing devices, it is the interdisciplinary treatment support network we foster which ensures patients are treated thoroughly, and in line with our evidence-based approach. Through these values we aim to provide reliable support to patients, dentists, and referring specialists in our shared quest to alleviate the strain of OSA on the community.SomnoMed continues to support cutting edge clinical research with improvements in patient health outcomes, which is regarded highly on the world sleep stage. While we manufacture potentially life changing devices, it is via the multidisciplinary network of dentists and sleep specialists that patient quality treatment is ensured.
SomnoMed® is a global medical device company, founded in 2004 and listed on the Australian Stock Exchange, operating in 28 countries. With headquarters in Sydney, Australia, and offices in Europe and the United States, SomnoMed® specializes in developing and manufacturing clinically proven medical devices for the treatment of Obstructive Sleep Apnea (OSA). Our oral appliances have successfully treated patients worldwide with mild and moderate OSA, providing comfortable and effective solutions.SomnoMed® is a leader in developing OSA devices, with each appliance custom-made using state-of-the-art technology to deliver precision, comfort, and first-time fit solutions. We are committed to continuous improvement, ensuring that our oral sleep medicine devices are highly effective and comfortable. Our devices have received FDA 510(k) clearance and are manufactured in accordance with ISO 13485 quality standards.Our vision is to lead in the treatment of patients suffering from obstructive sleep apnea and relevant adjacent conditions.Our mission is to advance the adoption, acceptance, and treatment of oral sleep apnea therapies by medical specialists, dentists, patients and insurers.While we create potentially life-changing devices, it is the interdisciplinary treatment support network we foster which ensures patients are treated thoroughly, and in line with our evidence-based approach. Through these values we aim to provide reliable support to patients, dentists, and referring specialists in our shared quest to alleviate the strain of OSA on the community.SomnoMed continues to support cutting edge clinical research with improvements in patient health outcomes, which is regarded highly on the world sleep stage. While we manufacture potentially life changing devices, it is via the multidisciplinary network of dentists and sleep specialists that patient quality treatment is ensured.
SomnoMed® is a global medical device company, founded in 2004 and listed on the Australian Stock Exchange, operating in 28 countries. With headquarters in Sydney, Australia, and offices in Europe and the United States, SomnoMed® specializes in developing and manufacturing clinically proven medical devices for the treatment of Obstructive Sleep Apnea (OSA). Our oral appliances have successfully treated patients worldwide with mild and moderate OSA, providing comfortable and effective solutions.SomnoMed® is a leader in developing OSA devices, with each appliance custom-made using state-of-the-art technology to deliver precision, comfort, and first-time fit solutions. We are committed to continuous improvement, ensuring that our oral sleep medicine devices are highly effective and comfortable. Our devices have received FDA 510(k) clearance and are manufactured in accordance with ISO 13485 quality standards.Our vision is to lead in the treatment of patients suffering from obstructive sleep apnea and relevant adjacent conditions.Our mission is to advance the adoption, acceptance, and treatment of oral sleep apnea therapies by medical specialists, dentists, patients and insurers.While we create potentially life-changing devices, it is the interdisciplinary treatment support network we foster which ensures patients are treated thoroughly, and in line with our evidence-based approach. Through these values we aim to provide reliable support to patients, dentists, and referring specialists in our shared quest to alleviate the strain of OSA on the community.SomnoMed continues to support cutting edge clinical research with improvements in patient health outcomes, which is regarded highly on the world sleep stage. While we manufacture potentially life changing devices, it is via the multidisciplinary network of dentists and sleep specialists that patient quality treatment is ensured.